From only the uploaded reference material (do not use external knowledge), identify all important diagrams, figures, flowcharts, graphs, tables, radiographs, clinical photographs, histopathology images, classification charts, and schematic illustrations related to " Host modulating agents " that are useful for answering an MDS Periodontology university theory examination question. For each item, provide: 1. Title/Name of the diagram/figure 2. Page number 3. Type (Diagram/Figure/Flowchart/Graph/Table/Radiograph/Clinical photograph/Histology/Schematic) 4. Importance (Very High/High/Moderate for university exams) 5. Why it is important in theory exams (1–2 lines) Output requirements: • Use only the uploaded references. • Do not summarize the chapter. • Do not explain Aggressive Periodontitis. • Do not include diagrams from other topics unless they are directly relevant. • List every important visual element found in the uploaded references • Present the output as a table sorted by exam importance, with Very High items first.
"host modulating" in ~/attachments/d42a9011-5fda-4ab1-87e7-c0a146676482
"Host Modulating" in ~/attachments/d42a9011-5fda-4ab1-87e7-c0a146676482
"host-modulating" in ~/attachments/d42a9011-5fda-4ab1-87e7-c0a146676482
"Host-Modulating" in ~/attachments/d42a9011-5fda-4ab1-87e7-c0a146676482
"Figure 5" in ~/attachments/d42a9011-5fda-4ab1-87e7-c0a146676482
"Table 5" in ~/attachments/d42a9011-5fda-4ab1-87e7-c0a146676482
"Figure 55" in ~/attachments/d42a9011-5fda-4ab1-87e7-c0a146676482
"Fig. 55" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/14 th ed Newman_and_Carranza's_Clinical_Periodontology_and_Implantology, - Copy - Copy.txt
"Table 55" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/14 th ed Newman_and_Carranza's_Clinical_Periodontology_and_Implantology, - Copy - Copy.txt
"sub-antimicrobial" in ~/attachments/d42a9011-5fda-4ab1-87e7-c0a146676482
"host modulat" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/Carranza's Clinical Periodontology, 10th Edition - Copy.txt
"Fig. 5" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/Carranza's Clinical Periodontology, 10th Edition - Copy.txt
"Table 5" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/Carranza's Clinical Periodontology, 10th Edition - Copy.txt
"Figure 53" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/Carranza's Clinical Periodontology, 10th Edition - Copy.txt
"Table 53" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/Carranza's Clinical Periodontology, 10th Edition - Copy.txt
"host modula" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/Clinical Periodontology and Implant Dentistry 6th Edition - Copy.txt
"host modula" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/Essentials of_Clinical Periodontology and Periodontics.md
"Figure" in .../d42a9011-5fda-4ab1-87e7-c0a146676482/Antibiotics and Antiseptics in Periodontal Therapy.txt
Visual Elements Related to Host Modulating Agents - MDS Periodontology University Theory Examination
| # | Title / Name of Diagram / Figure | Source & Page / Line Reference | Type | Importance | Why Important in Theory Exams |
|---|---|---|---|---|---|
| 1 | Fig. 55.1 - Schematic Illustration of the Pathogenesis of Periodontitis | Newman & Carranza 14th Ed., Ch. 55 (p. 670, line ~97397) | Schematic / Diagram | Very High | Directly explains the host immune-inflammatory cascade (PMNs, LPS, MMPs, cytokines, prostaglandins) that forms the biological rationale for HMT. Frequently asked as "explain the basis of host modulation therapy." Modified from Kornman 1999. |
| 2 | Fig. 55.2 - The Periodontal Balance | Newman & Carranza 14th Ed., Ch. 55 (p. 671, line ~97488) | Schematic / Diagram | Very High | The pivotal "balance" diagram showing how risk factors, proinflammatory mediators (IL-1, IL-6, PGE2, TNF-α, MMPs), and HMT tip the balance between disease and health. A classic theory exam diagram. |
| 3 | Fig. 55.5 - Schematic of Periodontal Pocket: Pleiotropic Mechanisms of Doxycycline (SDD) | Newman & Carranza 14th Ed., Ch. 55 (p. 675, line ~98064). (From Golub LM, Lee HM, Ryan ME et al. Adv Dent Res 1998;12:12) | Schematic / Diagram | Very High | Shows all non-antimicrobial mechanisms by which doxycycline inhibits connective tissue breakdown: MMP inhibition (via cation chelation, oxidative activation, cellular synthesis), ROS scavenging, cytokine downregulation (IL-1, IL-6, TNF-α, PGE2), collagen stimulation, osteoclast suppression. Standard exam answer for "mechanism of action of SDD." |
| 4 | Fig. 55.3 - Potential Adjunctive Therapeutic Approaches | Newman & Carranza 14th Ed., Ch. 55 (p. 672, line ~97739) | Schematic / Flowchart | Very High | Maps the entire pathologic cascade of periodontitis and identifies each point of intervention for adjunctive HMT (NSAIDs, bisphosphonates, SDD/Periostat, anticytokine agents). Essential for answering "classification and sites of action of HMAs." |
| 5 | Figure 53-6 - HMTs as Treatment for Periodontitis (Schematic of Pathogenesis with Targets) | Carranza's Clinical Periodontology 10th Ed., Ch. 53 (line ~53023) | Schematic / Diagram | Very High | Schematic showing pathogenesis of periodontitis with all targets and potential targets for adjunctive HMTs: SRP (bacterial challenge), SDD/CMTs (MMPs), anticytokine drugs (IL/TNF-α), bisphosphonates (osteoclast/bone). Labeled note: only SDD is FDA-licensed. Directly answers "targets of HMT." |
| 6 | Figure 53-2 / Fig. 55.5 (10th Ed. equivalent) - Schematic of Periodontal Pocket: Pleiotropic Mechanisms of Doxycycline | Carranza's Clinical Periodontology 10th Ed., Ch. 53 (line ~52565). (From Golub LM, Lee HM, Ryan ME et al. Adv Dent Res 12:12, 1998.) | Schematic / Diagram | Very High | Same landmark Golub schematic as Newman 14th Fig. 55.5 - identifies all non-antimicrobial mechanisms of doxycycline (SDD) in the periodontal pocket. Directly answerable in mechanism of action questions. |
| 7 | Table 55.1 - Clinical Trials of Sub-Antimicrobial-Dose Doxycycline (SDD) | Newman & Carranza 14th Ed., Ch. 55 (line ~98163) | Table | Very High | Summarizes all pivotal double-blind, placebo-controlled clinical studies of SDD (3, 6, 9-month duration), outcomes including probing depth reduction, CAL gain, collagenase inhibition, and special populations (smokers, PST-positive, diabetic, osteopenic). Essential for evidence-based theory answers. |
| 8 | Table 53-1 - Clinical Trials of SDD in Periodontal Disease | Carranza's Clinical Periodontology 10th Ed., Ch. 53 (line ~52591) | Table | Very High | Parallel table to Newman 14th Table 55.1 - summarizes controlled clinical trial data on SDD (probing depth, CAL, collagenase, bone resorption markers, ICTP). Hierarchic treatment response data including smokers included. Must-read for evidence-based exam answers. |
| 9 | Flowchart 15.1 - Production of Arachidonic Acid Metabolites | Essentials of Clinical Periodontology & Periodontics (S. Reddy), Ch. 15 (line ~20407) | Flowchart | Very High | Shows the arachidonic acid pathway (COX pathway producing prostaglandins, prostacyclins, thromboxane; LOX pathway producing leukotrienes), which is the target for NSAIDs as HMAs. Directly relevant to "role of NSAIDs in host modulation." |
| 10 | Fig. 55.4 - Complementary Treatment Strategies in Periodontitis | Newman & Carranza 14th Ed., Ch. 55 (p. 674, line ~97948) | Schematic / Diagram | High | Three-pronged illustration: (1) bacterial burden reduction (SRP, antimicrobials, surgery), (2) host response modulation (SDD/MMP inhibition), (3) risk factor modification (smoking cessation, diabetes control). Used in answering "comprehensive periodontal management incorporating HMT." |
| 11 | Figure 53-1 (10th Ed.) / Complementary Treatment Strategies in Periodontitis | Carranza's Clinical Periodontology 10th Ed., Ch. 53 (line ~52500) | Schematic / Diagram | High | Identical concept to Newman 14th Fig. 55.4 - best chance for clinical improvement from combining antibacterial (SRP + antimicrobials + surgery), host modulation (SDD), and risk factor modification. Useful when Carranza 10th is the primary textbook reference. |
| 12 | Table 15.1 - Proinflammatory vs. Anti-inflammatory Mediators (Periodontal Balance) | Essentials of Clinical Periodontology & Periodontics (S. Reddy), Ch. 15 (line ~20217) | Table | High | Lists the protective (anti-inflammatory) mediators in healthy individuals (IL-4, IL-10, IL-1ra, TIMPs) vs. destructive mediators in disease, forming the basis for "objectives of HMT." Relevant to restoring balance between mediators. |
| 13 | Table 15.2 - Biological Mechanism and Clinical Application of Host Modulation | Essentials of Clinical Periodontology & Periodontics (S. Reddy), Ch. 15 (line ~20507) | Table / Classification | High | Two-column table: biological mechanisms (immune/inflammatory response regulation, MMP production, arachidonic acid metabolites, bone metabolism) mapped to clinical HMT applications (SDD, CMTs, NSAIDs, bisphosphonates, HRT). A ready-made answer for "classification of HMAs with clinical applications." |
| 14 | Fig. 55.6 - Effect of SDD on GCF Collagenase (MMP-8, MMP-13) and ICTP | Newman & Carranza 14th Ed., Ch. 55 (p. 677, line ~98698). (From Golub LM, Lee HM, Greenwald RA et al. Inflamm Res 1997;46:310.) | Graph | High | Bar/line graphs showing 2-month SDD treatment significantly decreased MMP-8, MMP-13, and ICTP (bone collagen breakdown marker) in GCF vs. placebo. Provides biochemical/laboratory evidence for bone resorption reduction by SDD. Useful for evidence-based and short-note answers. |
| 15 | Figure 53-3 (10th Ed.) - Effect of SDD on GCF Collagenase (MMP-8, MMP-13) and ICTP | Carranza's Clinical Periodontology 10th Ed., Ch. 53 (line ~52772). (From Golub LM et al. Inflamm Res 46:310, 1997.) | Graph | High | Same landmark Golub graph as Newman 14th Fig. 55.6 - biochemical evidence of SDD reducing MMP-8, MMP-13, and ICTP vs. placebo at 1 and 2 months. Radioimmunoassay data. Useful for clinical evidence-based theory questions. |
| 16 | Figure 53-4 - Algorithm for Incorporating HMT (SDD) into Periodontal Management Protocols | Carranza's Clinical Periodontology 10th Ed., Ch. 53 (line ~52991) | Flowchart / Algorithm | High | A step-by-step treatment decision algorithm showing when to initiate SDD, when to reassess, when to continue/discontinue, and how to integrate SDD with maintenance therapy. Answerable in "clinical protocol for SDD use" questions. |
| 17 | Figure 53-5 - Clinical Photographs: Patient Treated with SRP + SDD | Carranza's Clinical Periodontology 10th Ed., Ch. 53 (line ~52996) | Clinical Photograph | High | A and B (initial): 35-year-old smoker with chronic periodontitis, generalized pocketing 5-8 mm. D, E, F (3 months post-SRP + 3-month SDD course): reduced inflammation, gingival shrinkage, improved tissue quality - patient continued smoking throughout. Demonstrates clinical outcome of HMT even in risk factor-present patients. |
| 18 | Table 3.4 - Clinical Studies of Sub-Antimicrobial-Dose Doxycycline (SDD) Therapy in Periodontal Disease | Antibiotics and Antiseptics in Periodontal Therapy (line ~9298) | Table | High | Comprehensive tabulation of clinical SDD studies (SRP ± SDD, outcomes: PPD, CAL, BOP, MMP levels, TIMP levels, wound healing indices). Includes study designs, sample sizes, and clinical outcomes across multiple populations. Useful for detailed evidence-based exam answers. |
| 19 | Classification of Host Modulatory Agents (Text-based Classification Chart) | Essentials of Clinical Periodontology & Periodontics (S. Reddy), Ch. 15 (line ~20415) | Classification Chart | Moderate | Two-part classification: (A) Agents preventing destruction - immune/inflammatory regulation, MMP inhibition (SDD, CMTs), arachidonic acid inhibitors (NSAIDs, COX-1/COX-2 inhibitors, LOX inhibitors), bone metabolism modulation (bisphosphonates, HRT, calcium); (B) Agents promoting resolution - resolvins, lipoxins, protectins, EMD, PDGF, BMP. Standard classification answer for theory exams. |
Notes on Coverage by Reference Source
| Reference | Chapter/Section | Key Figures/Tables Found |
|---|---|---|
| Newman & Carranza 14th Ed. | Chapter 55 (Host Modulating Therapy) | Fig. 55.1, 55.2, 55.3, 55.4, 55.5, 55.6; Table 55.1 |
| Carranza's 10th Ed. | Chapter 53 (Host Modulation Therapy) | Figure 53-1, 53-2, 53-3, 53-4, 53-5, 53-6; Table 53-1 |
| Essentials (S. Reddy) | Chapter 15 (Host Modulation in Periodontal Therapy) | Flowchart 15.1; Table 15.1; Table 15.2; Classification Chart |
| Antibiotics & Antiseptics in Periodontal Therapy | Chapter 3 (SDD/Host Modulation section) | Table 3.4 |
| Clinical Periodontology & Implant Dentistry 6th Ed. (Lindhe) | No dedicated HMA chapter found in uploaded content | No HMA-specific figures/tables present in extracted text |
| Pharmacology and Therapeutics for Dentistry | Only brief references to SDD/sub-antimicrobial use | No standalone HMA figures/tables extracted |